Thor Medical ASA (FRA:8NN)

Germany flag Germany · Delayed Price · Currency is EUR
0.3845
+0.0155 (4.20%)
At close: Feb 20, 2026
Market Cap138.05M +110.6%
Revenue (ttm)8.42K
Net Income-4.96M
EPS-0.02
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume763
Open0.3845
Previous Close0.3690
Day's Range0.3845 - 0.3845
52-Week Range0.1570 - 0.4840
Betan/a
RSI43.43
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 13
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NN
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements